Skip to content

CUBIST PHARMACEUTICALS INC

Delisted

CIK 912183fmd_0TTAXQQWYRBAZD4HQA2SP0AGC5Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2008 to Sep 30, 2014, 23 periods

Latest annual · FY2013

Millions
Total revenues
1,054
Gross profit
794
Operating income
26
Net income
94
Free cash flow
1

Latest quarter · Q3 FY2014

Millions
Total revenues
309
Gross profit
214
Operating income
68
Net income
23
Free cash flow
34
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2010 to FY2013
+18.3%
Revenue, 5 yearsFY2008 to FY2013
+19.4%

CUBIST PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2013FY2012ChangeSource
Revenue$1.1 billion$926.4 million+13.8%10-K 2014-02-25 · proof
Gross profit$794.1 million$696.3 million+14%10-K 2014-02-25 · proof
Operating income$26.4 million$237.1 million-88.9%10-K 2014-02-25 · proof
Cash from operating activities$16.4 million$215.7 million-92.4%10-K 2014-02-25 · proof
Free cash flow$900,000$197.5 million-99.5%10-K 2014-02-25 · proof
Total assets$3.1 billion$1.9 billion+62.8%10-Q 2014-11-07 · proof
Total liabilities$1.8 billion$941.6 million+86%10-Q 2014-11-07 · proof
Cash and cash equivalents$91.1 million$104 million-12.5%10-K 2014-02-25 · proof
What was CUBIST PHARMACEUTICALS INC's revenue in fiscal 2013?
CUBIST PHARMACEUTICALS INC reported revenue of $1.1 billion for fiscal 2013 (the year ended Dec 31, 2013), against $926.4 million the year before (+13.8%). Source: the 10-K filed with the SEC on Feb 25, 2014. SEC
What was CUBIST PHARMACEUTICALS INC's gross profit in fiscal 2013?
CUBIST PHARMACEUTICALS INC reported gross profit of $794.1 million for fiscal 2013 (the year ended Dec 31, 2013), against $696.3 million the year before (+14%). Source: the 10-K filed with the SEC on Feb 25, 2014. SEC
What was CUBIST PHARMACEUTICALS INC's operating income in fiscal 2013?
CUBIST PHARMACEUTICALS INC reported operating income of $26.4 million for fiscal 2013 (the year ended Dec 31, 2013), against $237.1 million the year before (-88.9%). Source: the 10-K filed with the SEC on Feb 25, 2014. SEC
What was CUBIST PHARMACEUTICALS INC's cash from operating activities in fiscal 2013?
CUBIST PHARMACEUTICALS INC reported cash from operating activities of $16.4 million for fiscal 2013 (the year ended Dec 31, 2013), against $215.7 million the year before (-92.4%). Source: the 10-K filed with the SEC on Feb 25, 2014. SEC
What was CUBIST PHARMACEUTICALS INC's free cash flow in fiscal 2013?
CUBIST PHARMACEUTICALS INC reported free cash flow of $900,000 for fiscal 2013 (the year ended Dec 31, 2013), against $197.5 million the year before (-99.5%). Source: the 10-K filed with the SEC on Feb 25, 2014. SEC
What are CUBIST PHARMACEUTICALS INC's total assets?
As of Dec 31, 2013, CUBIST PHARMACEUTICALS INC reported total assets of $3.1 billion, against $1.9 billion a year earlier (+62.8%). Source: the 10-Q filed with the SEC on Nov 7, 2014 (restated). SEC
What are CUBIST PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2013, CUBIST PHARMACEUTICALS INC reported total liabilities of $1.8 billion, against $941.6 million a year earlier (+86%). Source: the 10-Q filed with the SEC on Nov 7, 2014 (restated). SEC
What are CUBIST PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2013, CUBIST PHARMACEUTICALS INC reported cash and cash equivalents of $91.1 million, against $104 million a year earlier (-12.5%). Source: the 10-K filed with the SEC on Feb 25, 2014. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:912183&period_type=annual&limit=5"

Information only, not investment advice.